Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Cue Biopharma, Inc. (CUE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 3,000 shares @ $2.86, valued at $8.6k
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 9,325 shares @ $3.28, valued at $30.6k
Exercised 9,682 options to buy @ $2.86, valued at $27.7k
02/21/2023 4 NASSHORN PATRICIA (Chief Business Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 97,900 options to buy @ $3.21, valued at $314.3k
02/21/2023 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 125,500 options to buy @ $3.21, valued at $402.9k
01/19/2023 4 Levisetti Matteo (Chief Medical Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 110,000 options to buy @ $3.36, valued at $369.6k
01/19/2023 3 Levisetti Matteo (Chief Medical Officer) has filed a Form 3 on Cue Biopharma, Inc.
01/05/2023 4 Morich Frank (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
01/05/2023 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
01/05/2023 4 HOWSON TAMAR D (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
01/05/2023 4 Fletcher Aaron G.L. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
01/05/2023 4 DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
08/23/2022 4 Millar Kerri-Ann (CFO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 2,828 shares @ $3.05, valued at $8.6k
Exercised 6,667 restricted stock units @ $0
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Fletcher Aaron G.L. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 150,000 shares @ $3.52, valued at $528k
Bought 55,000 shares @ $3.34, valued at $183.7k
04/04/2022 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 7,068 shares @ $4.88, valued at $34.5k
Exercised 16,668 restricted stock units @ $0
04/04/2022 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 32,122 shares @ $4.88, valued at $156.8k
Gifted 10,000 shares @ $0
Exercised 75,000 restricted stock units @ $0
04/04/2022 4 Fletcher Aaron G.L. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 735,000 shares @ $4.76, valued at $3.5M
03/29/2022 4 NASSHORN PATRICIA (Chief Business Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $5.01, valued at $50.1k
03/29/2022 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 82,000 options to buy @ $6.91, valued at $566.6k
Granted 21,333 options to buy @ $5.01, valued at $106.9k
03/29/2022 4 Sandercock Colin (SVP, GENERAL COUNSEL) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 60,000 options to buy @ $6.91, valued at $414.6k
Granted 16,667 options to buy @ $5.01, valued at $83.5k
03/29/2022 4 Pienta Kenneth (Chief Medical Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 40,000 options to buy @ $5.01, valued at $200.4k
03/29/2022 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 100,000 options to buy @ $5.01, valued at $501k
03/29/2022 4 Millar Kerri-Ann (CFO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 85,000 options to buy @ $6.91, valued at $587.4k
Granted 10,000 options to buy @ $5.01, valued at $50.1k
01/05/2022 4 Fletcher Aaron G.L. (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.28, valued at $122.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy